• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$5.01 $0.00 (0.00%)

Quote as of

Inspire Pharmaceuticals, Inc.

NASDAQ:ISPH

Jump to this page for:

Related Resources

Merck & Co., Inc. to Close Inspire Pharmaceuticals, Inc. Facility, 51 Jobs Axed

7/1/2011 by BioSpace

Inspire Pharmaceuticals, Inc. (AzaSite (azithromycin ophthalmic solution) 1%)

5/19/2011 by PharmCast.com

Merck Completes Acquisition Of Inspire Pharmaceuticals, Inc.

5/18/2011 by Pharmaceutical Online

Merck Completes Acquisition of Inspire Pharmaceuticals

5/16/2011 by Pharmaceutical Processing

Merck announces completion of Inspire Pharma acquisition

5/16/2011 by Theflyonthewall.com

Merck Announces Successful Completion of Tender Offer for Shares of Inspire Pharmaceuticals, Inc. With Over 75 Percent of Shares Tendered

5/13/2011 by PharmiWeb.com - UK

Merck expects to complete acquistion of Inspire Pharma on May 16

5/13/2011 by Theflyonthewall.com

Inspire Pharmaceuticals Inc. Reports Operating Results (10-Q)

5/10/2011 by GuruFocus

Inspire Pharma reports Q1 EPS (21c) vs. consensus (22c)

5/10/2011 by Theflyonthewall.com

Inspire Pharmaceuticals fights shareholder lawsuit

4/28/2011 by The News & Observer - Raleigh NC

Merck and Inspire Pharma announce expiration of waiting period for tender offer

4/28/2011 by Theflyonthewall.com

Piper Jaffray's biotech and specialty pharma analysts hold a conference call

4/20/2011 by Theflyonthewall.com

Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc.

4/15/2011 by PharmiWeb.com - UK

Merck commences tender offer for shares of Inspire Pharma

4/15/2011 by Theflyonthewall.com

The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH

4/8/2011 by PR-inside - Austria

Merck to acquire Inspire Pharmaceuticals

4/7/2011 by Chain Drug Review

Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH

4/7/2011 by PR-inside - Austria

The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc.

4/7/2011 by StockWatch

Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc.

4/6/2011 by StockHouse

Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc.

4/6/2011 by StockWatch

Merck Inspired to Eye Growth

4/6/2011 by The Motley Fool

The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH

4/6/2011 by StockWatch

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Inspire Pharmaceuticals, Inc.

4/6/2011 by GlobeNewswire

Briscoe Law Firm and Powers Taylor LLP Investigate Inspire Pharmaceuticals, Inc. for Shareholders Concerning Merck Acquisition

4/6/2011 by PharmiWeb.com - UK

UPDATE; Deutsche Bank Raises PT on Inspire Pharmaceuticals to $5 (ISPH)

4/6/2011 by Benzinga

Inspire Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com

4/6/2011 by StockWatch

Inspire Pharmaceuticals Inc. is Today's Focus Stock on MicroStockProfit.com

4/6/2011 by GlobeNewswire

Merck To Acquire Inspire Pharmaceuticals, Inc.

4/6/2011 by Pharmaceutical Online

Option Midday Movers April 5

4/5/2011 by InvestorPlace

Inspire Pharma rises 24.4%

4/5/2011 by Theflyonthewall.com

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH

4/5/2011 by PR-inside - Austria

Merck to Acquire Inspire Pharmaceuticals, Inc.

4/5/2011 by StockWatch

Merck to acquire Inspire Pharma for $5.00 per share in cash

4/5/2011 by Theflyonthewall.com

Inspire Pharma trading halted, news pending

4/5/2011 by Theflyonthewall.com

SADIF Analytics releases new summary due diligence report for Inspire Pharmaceuticals, Inc.

2/21/2011 by PR-inside - Austria

Analyst Calls: BRCD, CREE, DUK, HRL, MOLX, RTN, SPWRA, VCLK, WTW ...

2/18/2011 by BloggingStocks

Inspire Pharma upgraded to Hold from Sell at Duncan-Williams

2/18/2011 by Theflyonthewall.com

Inspire Pharmaceuticals is cutting 65 jobs

2/17/2011 by The News & Observer - Raleigh NC

Inspire Pharma reports Q4 EPS (5c) vs. consensus (12c)

2/17/2011 by Theflyonthewall.com

Inspire Pharma sees Q1 restructuring charge of $10-$13M

2/17/2011 by Theflyonthewall.com
See More Articles...